Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ollendorf, D.
Right arrow Articles by Oster, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ollendorf, D.
Right arrow Articles by Oster, G
American Journal of Health-System Pharmacy, Vol 59, Issue 18, 1750-1754
Copyright © 2002 by American Society of Health-System Pharmacists

Articles

Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients

DA Ollendorf, M Vera-Llonch, and G Oster


The economic costs of clinical venous thromboembolism (VTE) in hospitalized patients after major orthopedic surgery were assessed. The discharge summaries and itemized bills from 220 U.S. acute care hospitals were examined. All patients who underwent total hip or knee replacement surgery or hip-fracture repair at these hospitals between January 1998 and June 1999 were identified and included in the study sample. Length of hospital stay, use of intensive care services, and costs of inpatient care were compared between patients with and without secondary diagnoses of deep vein thrombosis (DVT) without pulmonary embolism (PE) (DVT only) or PE with or without DVT. Mean length of hospital stay was more than twice as long for patients with VTE (11.5 and 12.4 days for DVT only and PE, respectively, versus 5.4 days for no VTE; p < 0.0001 for both comparisons). Mean time in the intensive care unit was roughly 10-fold greater (1.7 days for DVT only and 2.7 days for PE versus 0.2 day for no VTE; p < 0.0001). Mean total costs of inpatient care were almost twofold higher for patients with VTE ($17,114 for DVT only and $18,521 for PE versus $9,345 for no VTE; p < 0.0001 for both comparisons). Findings were unchanged in multivariate analyses controlling for differences in baseline characteristics between patients with and without VTE. Patients who develop in-hospital clinical VTE following major orthopedic surgery have significantly longer stays in the 'hospital and approximately twofold higher costs of inpatient care.
 



This article has been cited by other articles:


Home page
 JBJSHome page
R. Eisele, L. Kinzl, and T. Koelsch
Rapid-Inflation Intermittent Pneumatic Compression for Prevention of Deep Venous Thrombosis
J. Bone Joint Surg. Am., May 1, 2007; 89(5): 1050 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
D. A. MacDougall, A. L. Feliu, S. J. Boccuzzi, and J. Lin
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome.
Am. J. Health Syst. Pharm., October 15, 2006; 63(20 Suppl 6): S5 - S15.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
P. Tilleul, A. LaFuma, X. Colin, and Y. Ozier
Estimated Annual Costs of Prophylaxis and Treatment of Venous Thromboembolic Events Associated With Major Orthopedic Surgery in France
Clinical and Applied Thrombosis/Hemostasis, October 1, 2006; 12(4): 473 - 484.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
G. Oster, D. A Ollendorf, M. Vera-Llonch, M. Hagiwara, A. Berger, and J. Edelsberg
Economic Consequences of Venous Thromboembolism Following Major Orthopedic Surgery
Ann. Pharmacother., March 1, 2004; 38(3): 377 - 382.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Health-System Pharmacists.